Heron Therapeutics Ownership | Who Owns Heron Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Heron Therapeutics Ownership Summary


Heron Therapeutics is owned by 30.03% institutional investors, 0.68% insiders, and 69.29% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 18.89% of HRTX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.07% of its assets in Heron Therapeutics shares.

HRTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockHeron Therapeutics30.03%0.68%69.29%
SectorHealthcare Stocks 42.54%10.82%46.64%
IndustryBiotech Stocks 45.21%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rubric capital management lp29.10M18.89%$36.67M
Adage capital partners gp10.24M6.65%$12.90M
Blackrock funding, inc. /de9.99M6.48%$12.58M
Clearline capital lp9.71M6.31%$12.24M
Velan capital investment management lp8.75M5.68%$11.03M
Blackrock8.33M5.51%$29.14M
Vanguard group8.46M5.49%$10.66M
Palisade capital management, lp7.33M4.76%$9.23M
Tejara capital4.59M2.98%$5.78M
Baker bros. advisors lp4.25M2.76%$5.36M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Velan capital investment management lp8.75M10.36%$11.03M
Tejara capital4.59M3.02%$5.78M
Jw asset management3.29M1.99%$4.15M
Congress park capital2.89M1.13%$3.64M
Stonepine capital management850.10K0.87%$1.07M
Cm management750.00K0.79%$945.00M
Orchard capital management677.29K0.74%$853.38K
Clearline capital lp9.71M0.56%$12.24M
Richmond brothers572.12K0.46%$720.87K
Rubric capital management lp29.10M0.41%$36.67M

Top Buyers

HolderShares% AssetsChange
Clearline capital lp9.71M0.56%8.86M
Baker bros. advisors lp4.25M0.04%4.25M
Citigroup2.48M0.00%2.42M
Adage capital partners gp10.24M0.02%2.39M
Rubric capital management lp29.10M0.41%2.39M

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---6.51M
Point72 asset management---4.78M
Aigh capital management---3.01M
Price t rowe associates inc /md/76.64K--2.81M
Marshall wace, llp1.31M0.00%-1.59M

New Positions

HolderShares% AssetsChangeValue
Baker bros. advisors lp4.25M0.04%4.25M$5.36M
Caption management734.30K0.01%734.30K$925.21K
Pale fire capital se471.19K0.07%471.19K$593.70K
Connor, clark & lunn investment management83.69K0.00%83.69K$105.46M
Ieq capital79.03K0.00%79.03K$99.57K

Sold Out

HolderChange
Allspring global investments-1.00
Toronto dominion bank-9.00
Lindbrook capital-16.00
Mid-american wealth advisory group-24.00
Ifp advisors-35.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202590-45.78%46,256,389-62.08%300.48%31-63.10%27-18.18%
Jun 30, 20251742.35%131,460,8435.36%851.29%8714.47%34-26.09%
Mar 31, 20257-95.81%36,006,112-68.67%230.41%4-94.12%--100.00%
Dec 31, 202490-48.86%38,837,514-68.12%250.40%37-57.95%24-36.84%
Sep 30, 2024175-9.79%121,805,039-6.02%791.08%87-23.01%38-2.56%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF4.68M3.07%-
Vanguard Total Stock Mkt Idx Inv4.58M2.99%-101.04K
iShares Russell 2000 ETF3.74M2.44%-
Palisade Small Cap Core Equity3.19M2.09%-141.42K
Biotech Growth Ord2.58M1.70%2.58M
Franklin US Small Cap Growth Equity1.80M1.19%-
Vanguard Institutional Extnd Mkt Idx Tr1.55M1.01%-674.04K
Fidelity Small Cap Index1.54M1.00%339.16K
iShares Russell 2000 Value ETF1.18M0.77%-
State St Russell Sm/Mid Cp® Indx NL Cl C851.80K0.56%3.84K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 08, 2025Rubric Capital Management LP-Buy$3.58M
Aug 08, 2025Rubric Capital Management LP-Buy-
Aug 08, 2025Rubric Capital Management LP-Buy-
Aug 08, 2025Morgan Adam-Buy$105.02K
Aug 08, 2025Morgan Adam-Buy$2.65M

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q35-
2025 Q2--
2025 Q1--
2024 Q4--

HRTX Ownership FAQ


Who Owns Heron Therapeutics?

Heron Therapeutics shareholders are primarily institutional investors at 30.03%, followed by 0.68% insiders and 69.29% retail investors. The average institutional ownership in Heron Therapeutics's industry, Biotech Stocks , is 45.21%, which Heron Therapeutics falls below.

Who owns the most shares of Heron Therapeutics?

Heron Therapeutics’s largest shareholders are Rubric capital management lp (29.1M shares, 18.89%), Adage capital partners gp (10.24M shares, 6.65%), and Blackrock funding, inc. /de (9.99M shares, 6.48%). Together, they hold 32.03% of Heron Therapeutics’s total shares outstanding.

Does Blackrock own Heron Therapeutics?

Yes, BlackRock owns 5.51% of Heron Therapeutics, totaling 8.33M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 29.14M$. In the last quarter, BlackRock increased its holdings by 1.04M shares, a 14.27% change.

Who is Heron Therapeutics’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Heron Therapeutics’s biggest shareholder by percentage of total assets invested, with 10.36% of its assets in 8.75M Heron Therapeutics shares, valued at 11.03M$.

Who is the top mutual fund holder of Heron Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Heron Therapeutics shares, with 3.07% of its total shares outstanding invested in 4.68M Heron Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools